Publication:
Evaluation of rifampicin in the treatment of tuberculous meningitis in children

dc.contributor.authorPongsakdi Visudhiphanen_US
dc.contributor.authorSurang Chiemchanyaen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-04-19T14:09:15Z
dc.date.available2018-04-19T14:09:15Z
dc.date.issued1975-01-01en_US
dc.description.abstractOf the 20 patients given rifampicin and isoniazid, 19 survived and one died. Twelve patients recovered from the disease without any significant neurologic defect. Seven patients had moderate to severe handicaps which included hemiparesis in four, hydrocephalus in two, mental retardation in three, and blindness in one. There was no hearing deficit. The average hospital stay in this group was 3 1/2 week. Among the 13 patients given streptomycin, PAS, and isoniazid, four are dead. Only three patients recovered with a completely good condition. The remainder had either single or multiple neurologic defects. The moderate degree of nerve deafness was also observed in two patients. © 1975 The C. V. Mosby Company.en_US
dc.identifier.citationThe Journal of Pediatrics. Vol.87, No.6 PART 1 (1975), 983-986en_US
dc.identifier.doi10.1016/S0022-3476(75)80924-3en_US
dc.identifier.issn00223476en_US
dc.identifier.other2-s2.0-0016747754en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/10812
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0016747754&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleEvaluation of rifampicin in the treatment of tuberculous meningitis in childrenen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0016747754&origin=inwarden_US

Files

Collections